Description

Glycomet GP 3/850 is a medicine used for the management and treatment of type 2 diabetes mellitus. It is composed of two key ingredients – Glimepiride and Metformin. Glimepiride is an oral hypoglycemic agent that helps control blood sugar levels by stimulating insulin release from the pancreas. Metformin, on the other hand, is an antihyperglycemic agent that improves insulin sensitivity, reduces glucose production in the liver, and enhances glucose uptake by muscles. The combination of Glimepiride and Metformin in Glycomet GP 3/850 provides a synergistic effect in lowering blood glucose levels, resulting in improved glycemic control. This medication is typically prescribed when diet and exercise alone are insufficient to control blood sugar levels. It is important to note that Glycomet GP 3/850 should be taken as instructed by a healthcare provider and regular monitoring of blood glucose levels is necessary.

Additional information